PM Q4 Deep Dive: Smoke-Free Product Momentum and Regulatory Hurdles Shape Outlook

Tobacco company Philip Morris International (NYSE:PM) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% ...
Zacks Investment Research on MSN

ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?

Philip Morris International Inc. PM is accelerating its shift from traditional tobacco to reduced-risk products, with strong momentum in its flagship offerings — IQOS and ZYN. In the first quarter of ...

Philip Morris International Inc (PM) Q4 2025 Earnings Call Highlights: Strong Smoke-Free Growth ...

Philip Morris International Inc (PM) reports robust growth in smoke-free products and significant revenue achievements, ...

Philip Morris: Tobacco King Is Overbought - Wait For Dip Buying Opportunity

Philip Morris's robust performance metrics are already overbought while moderating its dividend yields, warranting some ...
Nasdaq

Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?

Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...

Philip Morris International Earnings Call Signals Smoke-Free Surge

Detailed price information for Philip Morris International Inc (PM-N) from The Globe and Mail including charting and trades.
Nasdaq

Philip Morris Transformation Accelerates With IQOS and ZYN Growth

Philip Morris International Inc.’s PM second-quarter 2025 results spotlight the central question for its long-term transformation: Can smoke-free momentum truly outweigh persistent declines in ...